Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who are already being seen at the high-risk clinic at OSUCCC-James, including those with a family history of breast cancer, a known gene change that increases breast cancer risk, a personal history of certain abnormal breast cell findings (called atypia or lobular carcinoma in situ), or a history of radiation treatment to the chest area
- People at high risk for breast cancer who are being seen in the surgical oncology clinic at Stefanie Spielman Comprehensive Breast Center, and who have been diagnosed with one of the following: atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), sclerosing adenosis (SA), or radial scars (RS) — these are specific findings that doctors sometimes discover during breast biopsies (confirm with trial site if unsure which category applies)
- People who are able to read and understand English
- People who are able to give their informed agreement to take part in the study
- People who agree to allow the study team to continue reviewing their medical records throughout the study period
Who may not be able to join:
- People who are currently incarcerated (in prison)
- People who are not able to speak and understand English
- People who have a personal history of ductal carcinoma in situ (DCIS) or invasive breast cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sagar D Sardesai, MSPH, PhD, Ohio State University Comprehensive Cancer Center
Phone: 800-293-5066
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to breast cancer events during study follow up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.